References
- Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29(1):252–260.
- Kim SJ, Choi CW, Mun YC, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-Hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC Cancer. 2011;11(1):321.
- Dizengof V, Levi I, Etzion O, et al. Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study. Eur J Gastroenterol Hepatol. 2020;32(5):569–574.
- Xiang Y, Yao L. Analysis of 78 cases of primary gastrointestinal lymphoma. J Healthc Eng. 2022;2022:3414302.
- Zhu T, Lei H, Wang YH, et al. Primary gastrointestinal lymphoma with intestinal perforation. QJM. 2022;2022:hcac227.
- Yang J, Liu T, Zhu Y, et al. A dynamic predictive nomogram of long-term survival in primary gastric lymphoma: a retrospective study. BMC Gastroenterol. 2022;22(1):347.
- Lin JL, Lin JX, Li P, et al. Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study. BMC Cancer. 2019;19(1):873.
- Malipatel R, Patil M, Pritilata Rout P, et al. Primary gastric lymphoma: clinicopathological profile. Euroasian J Hepatogastroenterol. 2018;8(1):6–10.
- Sadot E, Yahalom J, Do RK, et al. Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol. 2015;22(4):1176–1184.
- Kurzrock R, Redman J, Cabanillas F, et al. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin’s disease and with B symptoms. Cancer Res. 1993;53(9):2118–2122.
- Alvarez-Lesmes J, Chapman JR, Cassidy D, et al. Gastrointestinal tract lymphomas. Arch Pathol Lab Med. 2021;145(12):1585–1596.
- Warrick J, Luo J, Robirds D, et al. Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major Central-Midwestern United States tertiary care medical center. Diagn Pathol. 2012;7(1):76.
- Damaj G, Verkarre V, Delmer A, et al. Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol. 2003;14(4):623–629.
- Misdraji J, Harris NL, Hasserjian RP, et al. Primary follicular lymphoma of the gastrointestinal tract. Am J Surg Pathol. 2011;35(9):1255–1263.
- Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(3):401–404.
- Müller AM, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84(1):1–12.
- Cuttner J, Werther JL, McGlynn P, et al. Seroprevalence of Helicobacter pylori infection in patients with lymphoma. Leuk Lymphoma. 2001;40(5–6):591–597.
- Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995;345(8965):1591–1594.
- Wündisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23(31):8018–8024.
- Chen J, Wang J, Yang J, et al. Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin’s lymphoma after chemotherapy. PLOS One. 2013;8(7):e69400.
- Qi Z, Wang H, Gao G. Association of risk of non-Hodgkin’s lymphoma with hepatitis B virus infection: a meta-analysis. Int J Clin Exp Med. 2015;8(12):22167–22174.
- Su TH, Liu CJ, Tseng TC, et al. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin’s lymphoma and multiple myeloma. Aliment Pharmacol Ther. 2019;49(5):589–598.
- Nath A, Agarwal R, Malhotra P, et al. Prevalence of hepatitis B virus infection in non-Hodgkin lymphoma: a systematic review and meta-analysis. Intern Med J. 2010;40(9):633–641.
- Du HP, Yang QQ, Zhang YE. Bortezomib-based chemotherapy to treat refractory angioimmunoblastic T-cell lymphoma: a case report and review of the literature. Oncol Lett. 2016;11(3):2310–2314.
- Xu X, Wang Z, Yu Y, et al. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma. J Gastroenterol Hepatol. 2014;29(9):1678–1684.